LEO Pharma is developing a wearable device based on miniature sensors and plans to assess its clinical potential in dermatology drug development. The pharmaceutical company’s Boston-based R&D ...

Danish LEO Pharma announced yesterday (July 31st) that it has entered a binding agreement to purchase Bayer's global prescription dermatology portfolio, in line with its goal to help 125 million ...

LEO Pharma will host a symposium, “Chronic Hand Eczema: A New Day Is at Hand,” at 7 p.m. ET on March 6 at the Hyatt Regency Orlando ahead of the American Academy of Dermatology (AAD ...

A new survey commissioned by Leo Pharma confirms there’s plenty of ... The survey, conducted by Ipsos, queried nearly 200 dermatology providers, including doctors, nurse practitioners and ...

LEO Pharma. “Our research and work in CHE is a testament to our ambition to maintain the broadest global product portfolio in dermatology, and I am proud we can share this latest analysis from o ...

Spain-based drugmaker REIG JOFRE has signed a commercial agreement with LEO Pharma, a privately-held Danish firm specializing ...

LEO Pharma and Reig Jofre have entered into a partnership aimed at improving access to LEO’s psoriasis treatment in Europe.

An Ipsos survey commissioned by LEO Pharma Inc. reveals dermatology providers believe there is a lack of awareness and understanding of chronic hand eczema as a condition separate from eczema ...